Your institution may have access to this item. Find your institution then sign in to continue.
Title
A Phase II, Open‐label study to assess safety and management change using <sup>68</sup>Ga‐THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.